Semaglutide is a medication that acts on the GLP-1 receptor. Amla provides access to clinician review for compounded semaglutide where available and legally appropriate. Treatment and dosing are personalized based on the patient’s intake and clinical review. To ask whether it is an option for you, contact your clinician through https://portal.amlawellness.com/login.
What is semaglutide?
Definition of semaglutide as a GLP-1